DEA Bans Bromazolam: The Latest Sketchy Substance Gets Scheduled
Published Date: 3/16/2026
Rule
Summary
Starting March 16, 2026, bromazolam—a drug that can be dangerous—is temporarily placed in Schedule I, the strictest drug category. This means anyone making, selling, or using bromazolam will face tough rules and penalties until March 16, 2028. The goal? To keep the public safe from harm while the government watches closely.
Analyzed Economic Effects
5 provisions identified: 0 benefits, 5 costs, 0 mixed.
Bromazolam placed in Schedule I
If you make, sell, possess, or use bromazolam, it is temporarily placed in Schedule I of the Controlled Substances Act from March 16, 2026 through March 16, 2028 (with a possible one-year extension). That means handling bromazolam without authorization may lead to criminal, civil, or administrative penalties under Schedule I rules.
DEA registration and compliance required
If you handle bromazolam (manufacture, distribute, import, export, research, chemical analysis, or possess), you must be registered with the DEA as of March 16, 2026 and follow Schedule I security, labeling, inventory, recordkeeping, reporting, and order-form rules. Current DEA registrants have 30 calendar days from March 16, 2026 to comply with labeling, inventory, and recordkeeping requirements.
Manufacture limited to DEA-registered firms
Only DEA-registered manufacturers may manufacture bromazolam under an assigned manufacturing quota as of March 16, 2026. Manufacturing without DEA registration or outside assigned quota is unlawful and may lead to sanctions.
Surrender stocks if not registered
If you do not want or cannot obtain a Schedule I registration to handle bromazolam, you must surrender all quantities you currently hold as of March 16, 2026. Possession or handling after that date without authorization is unlawful and may lead to prosecution.
Research continuation and 90-day rule
If you are conducting research on bromazolam and are already registered to research another Schedule I substance on March 16, 2026, you may continue that bromazolam research if you submit a completed application to register or modify your registration within 90 calendar days after March 16, 2026. If DEA issues an order to show cause, you may not continue research; expedited hearings must be held not later than 45 calendar days after a hearing request.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-10253 — Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Starting May 22, 2026, the DEA is putting 2-fluorodeschloroketamine (2-FDCK) into Schedule I, meaning it’s now treated like the most dangerous drugs. This affects anyone who makes, sells, or uses it, adding strict rules and serious penalties. The temporary ban lasts two years, giving the government time to decide if it should stay permanent.
2026-10090 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) reviewed and decided on applications for special chemical mixtures that don’t fall under strict drug rules, covering requests from July 2025 to March 2026. Some mixtures got approved, others denied, and a few listings were fixed from earlier notices. If you’re involved with these chemicals, you’ve got until July 20, 2026, to share your thoughts—no fees or big costs involved, just your voice!
2026-09566 — Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Starting May 13, 2026, the DEA officially puts CUMYL-PEGACLONE—a chemical that can be risky—into Schedule I, the strictest drug category. This means anyone making, selling, or using it now faces tough rules and penalties. This move helps the U.S. follow international drug laws and keeps communities safer without any new fees or costs.
2026-08587 — Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
ANI Pharmaceuticals wants to import certain controlled drugs like Levorphanol and Tapentadol. People who make or use these drugs can share their thoughts or ask for a hearing by June 3, 2026. This move could affect drug availability and regulation, so keep an eye on the deadline to have your say!
2026-08588 — Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Patheon API Inc. wants to make large amounts of special research drugs like dimethyltryptamine and psilocybin. This affects researchers and companies involved in clinical trials, with a chance to comment or ask for a hearing by July 6, 2026. No money changes are mentioned, but this move could speed up important medical studies.
Previous / Next Documents
Previous: 2026-04990 — Revocation of the 30-Day Notification Requirement Prior to Termination of Lease for Nonpayment of Rent; Indefinite Delay of Effective Date
HUD is hitting the pause button on a new rule that would have stopped the 30-day heads-up before evicting tenants for not paying rent. This means public housing tenants and property owners won’t see changes just yet, as HUD reviews feedback and legal challenges. No rent-related notices are changing for now, so everyone can breathe easy until HUD decides the next move.
Next: 2026-05073 — Fisheries of the Northeastern United States; Scup Fishery; 2026 Scup Winter I Commercial Quota Harvested
The 2026 Winter I commercial quota for scup fish has been fully caught, so commercial fishing boats can’t land scup until April 30, 2026. This affects all federally permitted scup fishers in the Northeastern U.S., who must stop landing scup immediately to protect the fish population. The closure helps keep the fishery healthy and fair for everyone involved.